Barclays
GWPH

Barclays’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Barclays’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-14,000
Closed -$1.36M – 5258
2020
Q3 		$1.36M Buy
+14,000
New +$1.61M ﹤0.01% 2423
2020
Q2 		– Sell
-100
Closed -$9K – 6493
2020
Q1 		$9K Hold
100
– – ﹤0.01% 5860
2019
Q4 		$10K Sell
100
-600
-86% -$67.3K ﹤0.01% 6105
2019
Q3 		$81K Buy
700
+600
+600% +$91.1K ﹤0.01% 5634
2019
Q2 		$17K Hold
100
– – ﹤0.01% 6452
2019
Q1 		$17K Sell
100
-25,200
-100% -$3.75M ﹤0.01% 6418
2018
Q4 		$2.46M Buy
25,300
+24,900
+6,225% +$3.27M ﹤0.01% 2196
2018
Q3 		$69K Sell
400
-24,100
-98% -$3.48M ﹤0.01% 5864
2018
Q2 		$3.42M Buy
24,500
+15,800
+182% +$2.24M ﹤0.01% 2059
2018
Q1 		$980K Buy
8,700
+6,600
+314% +$830K ﹤0.01% 3238
2017
Q4 		$277K Buy
2,100
+1,400
+200% +$164K ﹤0.01% 4411
2017
Q3 		$71K Sell
700
-42,000
-98% -$4.5M ﹤0.01% 5163
2017
Q2 		$4.28M Buy
42,700
+12,700
+42% +$1.37M ﹤0.01% 1588
2017
Q1 		$3.63M Sell
30,000
-3,100
-9% -$380K ﹤0.01% 1567
2016
Q4 		$3.7M Sell
33,100
-117,200
-78% -$14.1M ﹤0.01% 1605
2016
Q3 		$19.9M Buy
+150,300
New +$14.4M 0.02% 553
2016
Q2 		– Sell
-17,800
Closed -$1.28M – 6760
2016
Q1 		$1.28M Buy
+17,800
New +$977K ﹤0.01% 2326

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Barclays's GWPH Position: Q2 2021 in Review

Barclays sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 19,524 shares — an estimated $4.24M sold.

Barclays first reported a position in GWPH in Q4 2013 and held it in 24 quarters. The position peaked at $64.3M in Q4 2018. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Barclays reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Barclays sold 19,524 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $4.24M.
  • Barclays first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2013 and held it in 24 quarters.
  • Barclays's GW Pharmaceuticals Plc American Depositary Shares position peaked at $64.3M in Q4 2018.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.